{
  "title": "关于 STAT6 在特应性皮炎中的全面综述",
  "sections": [
    {
      "title": "1. 引言",
      "id": "1",
      "subsections": [
        {
          "title": "1.1 STAT6 在特应性皮炎中的背景与意义",
          "id": "1.1",
          "research_focus": "提供 STAT6 研究领域的宏观背景，特别强调在特应性皮炎背景下的重要性。解释为何 STAT6 在特应性皮炎中至关重要，包括其在 Th2 免疫应答中的核心作用，并点出本篇综述旨在解决的临床或科研空白。",
          "keywords": [
            "STAT6 atopic dermatitis",
            "atopic dermatitis historical perspective",
            "atopic dermatitis epidemiology",
            "unmet medical needs atopic dermatitis",
            "atopic dermatitis pathophysiology"
          ]
        },
        {
          "title": "1.2 本篇综述的范围与目的",
          "id": "1.2",
          "research_focus": "清晰地界定本篇综述的边界，明确聚焦于特应性皮炎。明确陈述综述将要回答的具体问题，包括 STAT6 在特应性皮炎中的分子机制、结构特征和药物开发进展，并概述文章的整体结构。",
          "keywords": [
            "STAT6 atopic dermatitis review scope",
            "STAT6 atopic dermatitis research questions",
            "literature review purpose atopic dermatitis"
          ]
        }
      ]
    },
    {
      "title": "2. STAT6 基础分子机制在特应性皮炎中的作用",
      "id": "2",
      "subsections": [
        {
          "title": "2.1 STAT6 信号通路及其在特应性皮炎中的激活机制",
          "id": "2.1",
          "research_focus": "详细阐述 STAT6 信号通路，特别关注其在特应性皮炎中的作用机制和病理意义。搜索应侧重于特应性皮炎相关的开创性论文和最新发现，包括 IL-4/IL-13 信号传导。",
          "keywords": [
            "STAT6 signaling pathway atopic dermatitis",
            "STAT6 activation mechanism atopic dermatitis",
            "IL-4 STAT6 atopic dermatitis",
            "IL-13 STAT6 atopic dermatitis",
            "JAK-STAT pathway atopic dermatitis"
          ]
        },
        {
          "title": "2.2 STAT6 调控的基因表达与特应性皮炎病理关联",
          "id": "2.2",
          "research_focus": "在特应性皮炎的背景下，探讨 STAT6 调控的下游基因表达及其在疾病发生发展中的作用。重点关注与皮肤屏障功能、炎症反应相关的靶基因。",
          "keywords": [
            "STAT6 target genes atopic dermatitis",
            "gene regulation STAT6 atopic dermatitis",
            "transcriptional regulation atopic dermatitis",
            "skin barrier STAT6"
          ]
        }
      ]
    },
    {
      "title": "3. STAT6 靶点结构特征在特应性皮炎药物开发中的应用",
      "id": "3",
      "subsections": [
        {
          "title": "3.1 STAT6 蛋白结构特征及其在特应性皮炎中的功能意义",
          "id": "3.1",
          "research_focus": "针对特应性皮炎，详细回顾 STAT6 蛋白的晶体结构特征，包括 DNA 结合域、SH2 结构域等，及其与特应性皮炎病理机制的结构-功能关系。",
          "keywords": [
            "STAT6 crystal structure atopic dermatitis",
            "STAT6 protein domains atopic dermatitis",
            "SH2 domain STAT6 atopic dermatitis",
            "DNA binding domain STAT6 atopic dermatitis"
          ]
        },
        {
          "title": "3.2 STAT6 与其他蛋白的相互作用在特应性皮炎中的结构基础",
          "id": "3.2",
          "research_focus": "在特应性皮炎的背景下，探讨 STAT6 与其他关键蛋白（如 JAK 激酶、共激活因子）的结构相互作用，及其对特应性皮炎治疗策略的启示。",
          "keywords": [
            "STAT6 protein interactions atopic dermatitis",
            "STAT6 complex structure atopic dermatitis",
            "JAK-STAT interactions atopic dermatitis"
          ]
        }
      ]
    },
    {
      "title": "4. STAT6 靶向药物开发在特应性皮炎中的进展",
      "id": "4",
      "subsections": [
        {
          "title": "4.1 STAT6 小分子抑制剂在特应性皮炎中的临床前研究",
          "id": "4.1",
          "research_focus": "详细回顾针对特应性皮炎的 STAT6 小分子抑制剂的临床前研究进展，包括化合物筛选、体外活性、动物模型疗效和安全性评价。",
          "keywords": [
            "STAT6 inhibitors atopic dermatitis",
            "small molecule STAT6 inhibitors atopic dermatitis",
            "preclinical studies STAT6 atopic dermatitis",
            "animal models STAT6 atopic dermatitis"
          ]
        },
        {
          "title": "4.2 STAT6 靶向治疗在特应性皮炎中的临床试验进展",
          "id": "4.2",
          "research_focus": "在特应性皮炎的背景下，系统梳理 STAT6 相关靶向治疗的临床试验进展，包括直接和间接靶向 STAT6 通路药物的临床研究结果。",
          "keywords": [
            "STAT6 clinical trials atopic dermatitis",
            "targeted therapy atopic dermatitis STAT6",
            "phase trials STAT6 atopic dermatitis",
            "clinical development STAT6 atopic dermatitis"
          ]
        },
        {
          "title": "4.3 已上市药物通过 STAT6 通路在特应性皮炎中的应用",
          "id": "4.3",
          "research_focus": "针对特应性皮炎，分析已上市药物中通过调节 STAT6 通路发挥治疗作用的药物，包括其作用机制、临床疗效和安全性数据。",
          "keywords": [
            "approved drugs STAT6 atopic dermatitis",
            "marketed drugs STAT6 pathway",
            "dupilumab STAT6 atopic dermatitis",
            "JAK inhibitors STAT6 atopic dermatitis"
          ]
        }
      ]
    },
    {
      "title": "5. 结论与未来展望",
      "id": "5",
      "subsections": [
        {
          "title": "5.1 总结与综合",
          "id": "5.1",
          "research_focus": "总结特应性皮炎领域内所有核心章节的关键信息。综合这些发现，呈现对特应性皮炎中 STAT6 的深入理解，包括分子机制、结构特征和药物开发进展的整合分析。",
          "keywords": [
            "STAT6 atopic dermatitis research summary",
            "key evidence STAT6 atopic dermatitis",
            "literature synthesis STAT6 atopic dermatitis"
          ]
        },
        {
          "title": "5.2 未来方向与待解决的问题",
          "id": "5.2",
          "research_focus": "基于已回顾的证据，识别出特应性皮炎领域内当前 STAT6 研究知识体系中的关键空白。为特应性皮炎的未来 STAT6 研究提出具体、可行的方向，包括新型抑制剂开发、联合治疗策略等。",
          "keywords": [
            "atopic dermatitis future research directions STAT6",
            "knowledge gaps STAT6 atopic dermatitis",
            "unresolved problems STAT6 atopic dermatitis",
            "emerging technologies STAT6 atopic dermatitis"
          ]
        }
      ]
    }
  ]
}